Efficacy and safety of abacavir-containing combination antiretroviral therapy as first-line treatment of HIV infected children and adolescents: a systematic review and meta-analysis

Virological efficacy of abacavir: systematic review and meta-analysis

(2014) M. Cruciani et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Virologic Response in Children Treated With Abacavir-compared With Stavudine-based Antiretroviral Treatment

(2014) Karl-Günter Technau et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Efficacy and Safety of Darunavir/Ritonavir at 48 Weeks in Treatment-naïve, HIV-1–infected Adolescents

(2014) Patricia Flynn et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Anthropometric measurements and lipid profiles to detect early lipodystrophy in antiretroviral therapy experienced HIV-infected children in the CHAPAS-3-Trial

(2013) Victor Musiime et al.   ANTIVIRAL THERAPY

Use of Nucleoside Reverse Transcriptase Inhibitor–only Regimens in HIV-infected Children and Adolescents

(2013) Michael Neely et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

No Association of Abacavir Use With Myocardial Infarction

(2012) Xiao Ding et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Cardiovascular risks associated with abacavir and tenofovir exposure in HIV-infected persons

(2011) Andy I Choi et al.   AIDS

Abacavir use and cardiovascular disease events

(2011) Mario Cruciani et al.   AIDS

First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial

(2011)   LANCET INFECTIOUS DISEASES

Abacavir does not affect circulating levels of inflammatory or coagulopathic biomarkers in suppressed HIV: a randomized clinical trial

(2010) Allison Martin et al.   AIDS

Distribution of HLA-B alleles in a Ugandan HIV-infected adult population: NORA pharmacogenetic substudy of DART

(2010) Paula Munderi et al.   TROPICAL MEDICINE & INTERNATIONAL HEALTH

Effects of nucleoside reverse transcriptase inhibitor backbone on the efficacy of first-line boosted highly active antiretroviral therapy based on protease inhibitors: meta-regression analysis of 12 clinical trials in 5168 patients

(2009) A Hill et al.   HIV MEDICINE

Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients

(2008)   AIDS

Abacavir Hypersensitivity Reaction: an Update

(2008) Christine A Hughes et al.   ANNALS OF PHARMACOTHERAPY

Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration

(2008)   LANCET